Assessment of six GSD patients’ serum revealed higher levels of IL-6, Vascular Endothelial Growth Factor-A (VEGF-A), cross-linked telopeptide of type 1 collagen (ICTP), and sclerostin [67]. The gene discussed is IL6; the disease is disorder of glycogen metabolism.